T. Rowe Price Associates’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.73M | Buy |
461,115
+55,423
| +14% | +$929K | ﹤0.01% | 1169 |
|
|
2025
Q1 | $6.24M | Sell |
405,692
-1,643,696
| -80% | -$25.3M | ﹤0.01% | 1210 |
|
|
2024
Q4 | $45.2M | Buy |
2,049,388
+1,223,957
| +148% | +$27M | 0.01% | 785 |
|
|
2024
Q3 | $14.9M | Buy |
825,431
+571,302
| +225% | +$10.3M | ﹤0.01% | 1056 |
|
|
2024
Q2 | $4.13M | Buy |
254,129
+52,280
| +26% | +$850K | ﹤0.01% | 1282 |
|
|
2024
Q1 | $2.85M | Buy |
201,849
+36,295
| +22% | +$512K | ﹤0.01% | 1411 |
|
|
2023
Q4 | $1.73M | Buy |
165,554
+14,100
| +9% | +$147K | ﹤0.01% | 1608 |
|
|
2023
Q3 | $1.55M | Buy |
151,454
+11,100
| +8% | +$113K | ﹤0.01% | 1576 |
|
|
2023
Q2 | $1.06M | Buy |
140,354
+3,731
| +3% | +$28.1K | ﹤0.01% | 1778 |
|
|
2023
Q1 | $1.21M | Buy |
136,623
+11,993
| +10% | +$106K | ﹤0.01% | 1681 |
|
|
2022
Q4 | $1.14M | Buy |
124,630
+5,900
| +5% | +$53.8K | ﹤0.01% | 1704 |
|
|
2022
Q3 | $959K | Sell |
118,730
-600,174
| -83% | -$4.85M | ﹤0.01% | 1771 |
|
|
2022
Q2 | $5.41M | Buy |
718,904
+68,189
| +10% | +$513K | ﹤0.01% | 1414 |
|
|
2022
Q1 | $6.11M | Buy |
650,715
+116,033
| +22% | +$1.09M | ﹤0.01% | 1428 |
|
|
2021
Q4 | $4.28M | Buy |
534,682
+25,852
| +5% | +$207K | ﹤0.01% | 1517 |
|
|
2021
Q3 | $4.96M | Sell |
508,830
-9,000
| -2% | -$87.7K | ﹤0.01% | 1508 |
|
|
2021
Q2 | $5.13M | Buy |
517,830
+407,900
| +371% | +$4.04M | ﹤0.01% | 1496 |
|
|
2021
Q1 | $1.27M | Buy |
109,930
+3,700
| +3% | +$42.7K | ﹤0.01% | 1928 |
|
|
2020
Q4 | $1.03M | Buy |
106,230
+43,500
| +69% | +$420K | ﹤0.01% | 1924 |
|
|
2020
Q3 | $565K | Hold |
62,730
| – | – | ﹤0.01% | 2037 |
|
|
2020
Q2 | $773K | Buy |
62,730
+1,100
| +2% | +$13.6K | ﹤0.01% | 1894 |
|
|
2020
Q1 | $553K | Buy |
61,630
+31,730
| +106% | +$285K | ﹤0.01% | 1936 |
|
|
2019
Q4 | $293K | Buy |
29,900
+6,600
| +28% | +$64.7K | ﹤0.01% | 2320 |
|
|
2019
Q3 | $160K | Sell |
23,300
-9,530,028
| -100% | -$65.4M | ﹤0.01% | 2404 |
|
|
2019
Q2 | $88.2M | Buy |
9,553,328
+1,593,139
| +20% | +$14.7M | 0.01% | 683 |
|
|
2019
Q1 | $125M | Buy |
7,960,189
+1,116,003
| +16% | +$17.5M | 0.02% | 577 |
|
|
2018
Q4 | $106M | Buy |
6,844,186
+639,968
| +10% | +$9.87M | 0.02% | 595 |
|
|
2018
Q3 | $134M | Buy |
6,204,218
+403,265
| +7% | +$8.69M | 0.02% | 589 |
|
|
2018
Q2 | $141M | Buy |
5,800,953
+2,796,469
| +93% | +$68M | 0.02% | 567 |
|
|
2018
Q1 | $51.3M | Buy |
+3,004,484
| New | +$51.3M | 0.01% | 859 |
|
|
2017
Q3 | – | Sell |
-1,284,800
| Closed | -$42.7M | – | 2569 |
|
|
2017
Q2 | $42.7M | Sell |
1,284,800
-3,493,546
| -73% | -$116M | 0.01% | 889 |
|
|
2017
Q1 | $153M | Sell |
4,778,346
-2,470,483
| -34% | -$79.3M | 0.03% | 492 |
|
|
2016
Q4 | $263M | Buy |
7,248,829
+955,694
| +15% | +$34.6M | 0.05% | 361 |
|
|
2016
Q3 | $290M | Buy |
6,293,135
+157,944
| +3% | +$7.27M | 0.06% | 319 |
|
|
2016
Q2 | $308M | Sell |
6,135,191
-269,555
| -4% | -$13.5M | 0.07% | 301 |
|
|
2016
Q1 | $343M | Buy |
6,404,746
+19,407
| +0.3% | +$1.04M | 0.07% | 289 |
|
|
2015
Q4 | $419M | Sell |
6,385,339
-671,571
| -10% | -$44.1M | 0.09% | 245 |
|
|
2015
Q3 | $398M | Sell |
7,056,910
-469,554
| -6% | -$26.5M | 0.09% | 251 |
|
|
2015
Q2 | $445M | Buy |
7,526,464
+114,904
| +2% | +$6.79M | 0.09% | 245 |
|
|
2015
Q1 | $462M | Buy |
7,411,560
+1,326,854
| +22% | +$82.7M | 0.1% | 251 |
|
|
2014
Q4 | $350M | Buy |
6,084,706
+755,668
| +14% | +$43.5M | 0.07% | 308 |
|
|
2014
Q3 | $286M | Buy |
5,329,038
+690,557
| +15% | +$37.1M | 0.06% | 344 |
|
|
2014
Q2 | $243M | Buy |
+4,638,481
| New | +$243M | 0.05% | 391 |
|
|
2013
Q3 | – | Sell |
-404,700
| Closed | -$15.9M | – | 2469 |
|
|
2013
Q2 | $15.9M | Buy |
+404,700
| New | +$15.9M | ﹤0.01% | 1135 |
|